CMR

GlaxoSmithKline Vaccine Unlikely To Receive US Approval For 2 Years London-The new cervical cancer vaccine that has been submitted by GlaxosmithKline for approval in the United States is not likely to receive the go ahead until 2010 at the earliest. The company has released a new timetable that sets its expectant date for approval of its new Cervarix Cancer Vaccine at 2010 at the earliest. Read More

Cure Worked On Mice To Receive Testing On People Winston-Salem NC- Beginning this week at Wake Forest University an exciting potential therapy that has cured cancer in mice will start human testing. In the last 2 years there have been several mice that have been cured, and the testing has received approval from the federal Food and Drug Administration to begin human trials. The Cancer therapy involves transfusion of white blood cells into the body of cancer patients. Read More